Altrafin AG’s S&P Global SPGI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.15M Sell
12,637
-9,140
-42% -$3.86M 2.02% 16
2026
Q1
$9.26M Sell
21,777
-970
-4% -$450K 3.19% 9
2025
Q4
$11.9M Buy
22,747
+1,769
+8% +$875K 3.77% 7
2025
Q3
$10.2M Sell
20,978
-148
-0.7% -$79.2K 3.24% 11
2025
Q2
$11.1M Sell
21,126
-999
-5% -$499K 3.76% 9
2025
Q1
$11.2M Buy
22,125
+2,122
+11% +$1.08M 4.37% 7
2024
Q4
$9.96M Buy
20,003
+282
+1% +$143K 3.45% 10
2024
Q3
$10.2M Buy
19,721
+826
+4% +$409K 3.67% 10
2024
Q2
$8.43M Buy
18,895
+928
+5% +$398K 3.11% 11
2024
Q1
$7.64M Buy
17,967
+2,004
+13% +$869K 2.77% 13
2023
Q4
$7.03M Buy
15,963
+3,287
+26% +$1.3M 2.71% 13
2023
Q3
$4.63M Buy
+12,676
New +$4.98M 2.02% 20

Other funds holding SPGI

Altrafin AG's SPGI Position: Q2 2026 in Review

Altrafin AG reduced its S&P Global (SPGI) stake by 42% in Q2 2026, selling an estimated $3.86M and leaving 12,637 shares worth $5.15M. The position accounts for 2.02% of the portfolio, ranked #16.

Altrafin AG first reported a position in SPGI in Q3 2023 and has held it in 12 quarters since. The position peaked at $11.9M in Q4 2025. 2,014 funds tracked by Wall St. Rank hold SPGI as of Q2 2026.

  • Altrafin AG held 12,637 shares of S&P Global worth $5.15M as of Q2 2026.
  • Altrafin AG sold 9,140 S&P Global shares in Q2 2026, an estimated $3.86M.
  • S&P Global made up 2.02% of Altrafin AG's portfolio in Q2 2026, its #16 holding.
  • Altrafin AG first reported a position in S&P Global in Q3 2023 and has held it in 12 quarters since.
  • Altrafin AG's S&P Global position peaked at $11.9M in Q4 2025.
  • 2,014 funds tracked by Wall St. Rank held S&P Global as of Q2 2026.

Based on Altrafin AG's 13F filing for Q2 2026, filed 15 Jul 2026.